Pursuant to Regulation 33 and other applicable provisions of the SEBI (Listing Obligations\r\nand Disclosure Requirements) Regulations, 2015 ('SEBI LODR'), we wish to inform you\r\nthat the Board of Directors (the 'Board') of ADS Diagnostic Limited ('the Company') at its\r\nmeeting held today i.e. Thursday, November 12th, 2026 considered and approved the\r\nUnaudited Standalone Financial Results of the Company for the quarter ended 30th\r\nSeptember, 2026.